346 related articles for article (PubMed ID: 30553110)
1. A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study.
Yuan L; Huang C; Liu-Kreyche P; Voronin K; Fancher RM; Allentoff A; Zheng N; Iyer R; Zhu L; Pillutla R; Ji QC
J Pharm Biomed Anal; 2019 Feb; 165():198-206. PubMed ID: 30553110
[TBL] [Abstract][Full Text] [Related]
2. Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies.
Gu H; Wang J; Aubry AF; Jiang H; Zeng J; Easter J; Wang JS; Dockens R; Bifano M; Burrell R; Arnold ME
Anal Chem; 2012 Jun; 84(11):4844-50. PubMed ID: 22540405
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity-based analytical approaches to support human absolute bioavailability studies.
Xu XS; Jiang H; Christopher LJ; Shen JX; Zeng J; Arnold ME
Bioanalysis; 2014 Feb; 6(4):497-504. PubMed ID: 24568352
[TBL] [Abstract][Full Text] [Related]
4. Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay.
Jiang H; Zeng J; Li W; Bifano M; Gu H; Titsch C; Easter J; Burrell R; Kandoussi H; Aubry AF; Arnold ME
Anal Chem; 2012 Nov; 84(22):10031-7. PubMed ID: 23106420
[TBL] [Abstract][Full Text] [Related]
5. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
[TBL] [Abstract][Full Text] [Related]
6. Bio-generation of stable isotope-labeled internal standards for absolute and relative quantitation of phase II drug metabolites in plasma samples using LC-MS/MS.
Li P; Li Z; Beck WD; Callahan PM; Terry AV; Bar-Peled M; Bartlett MG
Anal Bioanal Chem; 2015 May; 407(14):4053-63. PubMed ID: 25804729
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract][Full Text] [Related]
8. Eliminating Preparation of Multisample External Calibration Curves and Dilution of Study Samples Using the Multiple Isotopologue Reaction Monitoring (MIRM) Technique in Quantitative LC-MS/MS Bioanalysis.
Gu H; Zhao Y; DeMichele M; Zheng N; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2019 Jul; 91(13):8652-8659. PubMed ID: 31180205
[TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of the root cause of non-linearity in liquid chromatography/tandem mass spectrometry bioanalytical assays and strategy to predict and extend the linear standard curve range.
Yuan L; Zhang D; Jemal M; Aubry AF
Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1465-74. PubMed ID: 22592990
[TBL] [Abstract][Full Text] [Related]
10. Precision and accuracy in the quantitative analysis of biological samples by accelerator mass spectrometry: application in microdose absolute bioavailability studies.
Gao L; Li J; Kasserra C; Song Q; Arjomand A; Hesk D; Chowdhury SK
Anal Chem; 2011 Jul; 83(14):5607-16. PubMed ID: 21627104
[TBL] [Abstract][Full Text] [Related]
11. Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose.
Roosendaal J; Groenland SL; Rosing H; Lucas L; Venekamp N; Nuijen B; Huitema ADR; Beijnen JH; Steeghs N
Eur J Clin Pharmacol; 2020 Aug; 76(8):1075-1082. PubMed ID: 32430518
[TBL] [Abstract][Full Text] [Related]
12. In-Sample Calibration Curve Using Multiple Isotopologue Reaction Monitoring of a Stable Isotopically Labeled Analyte for Instant LC-MS/MS Bioanalysis and Quantitative Proteomics.
Gu H; Zhao Y; DeMichele M; Zheng N; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2019 Feb; 91(3):2536-2543. PubMed ID: 30615432
[TBL] [Abstract][Full Text] [Related]
13. Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MS.
Liu A; Lute J; Gu H; Wang B; Trouba KJ; Arnold ME; Aubry AF; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():29-40. PubMed ID: 26209768
[TBL] [Abstract][Full Text] [Related]
14. A simplified and completely automated workflow for regulated LC-MS/MS bioanalysis using cap-piercing direct sampling and evaporation-free solid phase extraction.
Zheng N; Buzescu A; Pasas-Farmer S; Arnold ME; Ouyang Z; Jemal M; Peng Q; Van Vleet T; Zeng J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():64-74. PubMed ID: 23435343
[TBL] [Abstract][Full Text] [Related]
15. Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry.
Radovanovic M; Jones G; Day RO; Galettis P; Norris RLG
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():57-64. PubMed ID: 35520954
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
Chavez-Eng CM; Lutz RW; Li H; Goykhman D; Bateman KP; Woolf E
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():204-14. PubMed ID: 26773885
[TBL] [Abstract][Full Text] [Related]
18. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?
Stokvis E; Rosing H; Beijnen JH
Rapid Commun Mass Spectrom; 2005; 19(3):401-7. PubMed ID: 15645520
[TBL] [Abstract][Full Text] [Related]
19. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
20. Overcoming interference with the detection of a stable isotopically labeled microtracer in the evaluation of beclabuvir absolute bioavailability using a concomitant microtracer approach.
Jiang H; Titsch C; Zeng J; Jones B; Joyce P; Gandhi Y; Turley W; Burrell R; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2017 Sep; 143():9-16. PubMed ID: 28544885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
